These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1149 related articles for article (PubMed ID: 18985950)

  • 81. Medicare program; contract year 2016 policy and technical changes to the Medicare Advantage and the Medicare Prescription Drug Benefit programs. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2015 Feb; 80(29):7911-66. PubMed ID: 25735051
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Medicare program; rural health clinics: amendments to participation requirements and payment provisions; and establishment of a quality assessment and performance improvement program; suspension of effectiveness. Interim final rule with comment period; partial suspension of effectiveness.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2006 Sep; 71(184):55341-7. PubMed ID: 17017468
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Part D decisions: like other employers, many states are collecting a new federal subsidy for maintaining retiree drug coverage--but for many, that's not their "final answer".
    Burton R; Folkemer D
    State Legis; 2006 Sep; 32(8):26-7. PubMed ID: 16958187
    [No Abstract]   [Full Text] [Related]  

  • 84. Medicare Part D--the product of a broken process.
    Slaughter LM
    N Engl J Med; 2006 Jun; 354(22):2314-5. PubMed ID: 16738267
    [No Abstract]   [Full Text] [Related]  

  • 85. Impact of the Medicare prescription drug benefit on home- and community-based services waiver programs.
    Milligan CJ
    Issue Brief (Commonw Fund); 2005 Apr; (815):1-8. PubMed ID: 15856612
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Medicare prescription drug/reform act: medicine chest or Pandora's box?
    Hager MH
    J Am Diet Assoc; 2004 Jun; 104(6):890-1. PubMed ID: 15175585
    [No Abstract]   [Full Text] [Related]  

  • 87. States' control of prescription drug spending: a heterogeneous approach.
    Morden NE; Sullivan SD
    Health Aff (Millwood); 2005; 24(4):1032-8. PubMed ID: 16012143
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The Medicare Prescription Drug, Improvement and Modernization Act and the impact on care of people with chronic illness: benefit design and implementation issues.
    Schlosberg C
    Care Manag J; 2004; 5(2):113-21. PubMed ID: 16047917
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Medicare program; End Stage Renal Disease Program; responsibilities of network organizations--HCFA. Final rule.
    Fed Regist; 1988 Jan; 53(13):1617-20. PubMed ID: 10302132
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Medicare Part D: selected issues for pharmacists and beneficiaries in 2007.
    Kilian J; Stubbings J
    J Manag Care Pharm; 2007; 13(1):59-65. PubMed ID: 17269838
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Medicare program; changes to the hospital outpatient prospective payment system and calendar year 2005 payment rates. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2004 Nov; 69(219):65681-6233. PubMed ID: 15551492
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Medicare and Medicaid programs; programs of all-inclusive care for the elderly (PACE); program revisions. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2006 Dec; 71(236):71243-337. PubMed ID: 17171853
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Medicare program; coverage of home intravenous drug therapy services--HCFA. Proposed rule.
    Fed Regist; 1989 Sep; 54(172):37422-38. PubMed ID: 10303831
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The impact of Medicare Part D on prescription drug use by the elderly.
    Lichtenberg FR; Sun SX
    Health Aff (Millwood); 2007; 26(6):1735-44. PubMed ID: 17978393
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Medicare program: changes to the Medicare claims appeal procedures. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Mar; 70(44):11419-99. PubMed ID: 15754467
    [TBL] [Abstract][Full Text] [Related]  

  • 96. What does the Medicare prescription drug legislation mean for the American cardiologist?
    Schwartz JB; Redberg RF
    Am J Geriatr Cardiol; 2005; 14(6):317-24. PubMed ID: 16276130
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Medicare program; revised payment system policies for services furnished in ambulatory surgical centers (ASCs) beginning in CY 2008. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2007 Aug; 72(148):42469-626. PubMed ID: 17682288
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Medicare Advantage increases cap payments third straight year.
    Capitation Manag Rep; 2005 May; 12(5):55-7, 49. PubMed ID: 16111016
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Clinton proposal begins debate on Medicare prescription benefit.
    Weiss HP
    Balance; 1999; 3(5):6-7. PubMed ID: 10662381
    [No Abstract]   [Full Text] [Related]  

  • 100. Advocating for a Medicare prescription drug benefit.
    Rother J
    Yale J Health Policy Law Ethics; 2003; 3(2):279-90. PubMed ID: 14577144
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.